CRISPR-Cas9-Mediated Modification of the NOD Mouse Genome With Ptpn22R619W Mutation Increases Autoimmune Diabetes

被引:29
作者
Lin, Xiaotian [1 ]
Pelletier, Stephane [2 ]
Gingras, Sebastien [2 ,3 ]
Rigaud, Stephanie [1 ]
Maine, Christian J. [1 ]
Marquardt, Kristi [1 ]
Dai, Yang D. [1 ]
Sauer, Karsten [1 ]
Rodriguez, Alberto R. [4 ]
Martin, Greg [4 ]
Kupriyanov, Sergey [4 ]
Jiang, Ling [5 ]
Yu, Liping [5 ]
Green, Douglas R. [2 ]
Sherman, Linda A. [1 ]
机构
[1] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA
[2] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA
[3] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA
[4] Scripps Res Inst, Murine Genet Core, La Jolla, CA 92037 USA
[5] Univ Colorado, Sch Med, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA
基金
美国国家卫生研究院;
关键词
OF-FUNCTION VARIANT; ONE-STEP GENERATION; TYROSINE PHOSPHATASE; DISEASE; MICE; AUTOANTIBODIES; SUSCEPTIBILITY; MODEL;
D O I
10.2337/db16-0061
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An allelic variant of protein tyrosine phosphatase non-receptor type 22 (PTPN22), PTPN22(R620W), is strongly associated with type 1 diabetes (T1D) in humans and increases the risk of T1D by two-to fourfold. The NOD mouse is a spontaneous T1D model that shares with humans many genetic pathways contributing to T1D. We hypothesized that the introduction of the murine orthologous Ptpn22(R619W) mutation to the NOD genome would enhance the spontaneous development of T1D. We microinjected CRISPR-Cas9 and a homology-directed repair template into NOD single-cell zygotes to introduce the Ptpn22(R619W) mutation to its endogenous locus. The resulting Ptpn22(R619W) mice showed increased insulin autoantibodies and earlier onset and higher penetrance of T1D. This is the first report demonstrating enhanced T1D in a mouse modeling human PTPN22(R620W) and the utility of CRISPR-Cas9 for direct genetic alternation of NOD mice.
引用
收藏
页码:2134 / 2138
页数:5
相关论文
共 25 条
  • [1] Tyrosine Phosphatase PTPN22: Multifunctional Regulator of Immune Signaling, Development, and Disease
    Bottini, Nunzio
    Peterson, Erik J.
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, VOL 32, 2014, 32 : 83 - 119
  • [2] Gene Targeting in NOD Mouse Embryos Using Zinc-Finger Nucleases
    Chen, Yi-Guang
    Forsberg, Matthew H.
    Khaja, Shamim
    Ciecko, Ashley E.
    Hessner, Martin J.
    Geurts, Aron M.
    [J]. DIABETES, 2014, 63 (01) : 68 - 74
  • [3] Multiplex Genome Engineering Using CRISPR/Cas Systems
    Cong, Le
    Ran, F. Ann
    Cox, David
    Lin, Shuailiang
    Barretto, Robert
    Habib, Naomi
    Hsu, Patrick D.
    Wu, Xuebing
    Jiang, Wenyan
    Marraffini, Luciano A.
    Zhang, Feng
    [J]. SCIENCE, 2013, 339 (6121) : 819 - 823
  • [4] A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models
    Dai, Xuezhi
    James, Richard G.
    Habib, Tania
    Singh, Swati
    Jackson, Shaun
    Khim, Socheath
    Moon, Randall T.
    Liggitt, Denny
    Wolf-Yadlin, Alejandro
    Buckner, Jane H.
    Rawlings, David J.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (05) : 2024 - 2036
  • [5] Themis sets the signal threshold for positive and negative selection in T-cell development
    Fu, Guo
    Casas, Javier
    Rigaud, Stephanie
    Rybakin, Vasily
    Lambolez, Florence
    Brzostek, Joanna
    Hoerter, John A. H.
    Paster, Wolfgang
    Acuto, Oreste
    Cheroutre, Hilde
    Sauer, Karsten
    Gascoigne, Nicholas R. J.
    [J]. NATURE, 2013, 504 (7480) : 441 - +
  • [6] PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells
    Hasegawa, K
    Martin, F
    Huang, GM
    Tumas, D
    Diehl, L
    Chan, AC
    [J]. SCIENCE, 2004, 303 (5658) : 685 - 689
  • [7] A SNP in the Immunoregulatory Molecule CTLA-4 Controls mRNA Splicing In Vivo but Does Not Alter Diabetes Susceptibility in the NOD Mouse
    Jakubczik, Fabian
    Jones, Ken
    Nichols, Jennifer
    Mansfield, William
    Cooke, Anne
    Holmes, Nick
    [J]. DIABETES, 2016, 65 (01) : 120 - 128
  • [8] Non-HLA gene effects on the disease process of type 1 diabetes: From HLA susceptibility to overt disease
    Lempainen, Johanna
    Laine, Antti-Pekka
    Hammais, Anna
    Toppari, Jorma
    Simell, Olli
    Veijola, Riitta
    Knip, Mikael
    Ilonen, Jorma
    [J]. JOURNAL OF AUTOIMMUNITY, 2015, 61 : 45 - 53
  • [9] Efficient genetic manipulation of the NOD-Rag1-/-IL2RgammaC-null mouse by combining in vitro fertilization and CRISPR/Cas9 technology
    Li, Feng
    Cowley, Dale O.
    Banner, Debra
    Holle, Eric
    Zhang, Liguo
    Su, Lishan
    [J]. SCIENTIFIC REPORTS, 2014, 4
  • [10] RNA-Guided Human Genome Engineering via Cas9
    Mali, Prashant
    Yang, Luhan
    Esvelt, Kevin M.
    Aach, John
    Guell, Marc
    DiCarlo, James E.
    Norville, Julie E.
    Church, George M.
    [J]. SCIENCE, 2013, 339 (6121) : 823 - 826